Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shanjinlian Soft Capsule for Common Cold (Wind-Heat Pattern)
CTR20200513Phase 2Active
- Sponsor
- Shanxi Yellow River Traditional Chinese Medicine
- Start
- Apr 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shanjinlian in nasopharyngitis, sponsored by Shanxi Yellow River Traditional Chinese Medicine. Started Apr 2020; status: active.
02
Drugs
Shanjinlian
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20200513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200513.